Top Markets
Coin of the day
CANbridge Pharmaceuticals Inc. CANbridge Pharmaceuticals Inc.

CANbridge Pharmaceuticals Inc.

1228
Rank in Stocks #21196
CANbridge Pharmaceuticals Inc. is a biopharmaceutical company focused on the... CANbridge Pharmaceuticals Inc. is a biopharmaceutical company focused on the global research, development, and commercialization of treatments for rare disorders and various cancer types. The company's marketed products include Hunterase, an enzyme replacement therapy for Hunter syndrome; NERLYNX (Neratinlib), a powerful, irreversible tyrosine kinase inhibitor targeting HER2-positive breast cancer; and Caphosol Mouth Rinse, used to alleviate temporary and persistent dry mouth and throat. Its robust development pipeline features several investigational therapies: CAN008, an artificially engineered antibody-like fully human fusion protein being developed for glioblastoma multiforme; CAN108, an orally administered reversible inhibitor of the ileal bile acid transporter, designed to treat rare cholestatic liver diseases; CAN106, a humanized monoclonal antibody against complement C5 for complement-mediated conditions; CAN103 and CAN104, both recombinant human enzyme replacement therapies (ERTs); CAN105, a bispecific antibody; and gene therapy programs CAN201 and CAN202, both utilizing adeno-associated virus (AAV) sL65 capsid technology. Established in 2012, CANbridge Pharmaceuticals Inc. is based in Beijing, China.
Share Price
$0.26544693
Last synced: 2026-08-21
Market Cap
$112.77M
Change (1 day)
-0.72%
Change (1 year)
-16.36%
Country
CN
Trade CANbridge Pharmaceuticals Inc. (1228)

Category

Dividend history for CANbridge Pharmaceuticals Inc. (1228)
CANbridge Pharmaceuticals Inc. (stock symbol: 1228) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for CANbridge Pharmaceuticals Inc. (1228) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
0.00%
US
0.00%
NL
0.00%
US
64.00%
AU
0.00%
CH